发明名称 Heteroarylalkanoic acids as integrin receptor antagonists
摘要 The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively antagonizing the alpha<SUB>V</SUB>beta<SUB>3 </SUB>and/or the alpha<SUB>V</SUB>beta<SUB>5 </SUB>integrin without significantly antagonizing the IIb/IIIa or alpha<SUB>V</SUB>beta<SUB>6 </SUB>integrin.
申请公布号 AU6987601(A) 申请公布日期 2001.12.24
申请号 AU20010069876 申请日期 2001.06.15
申请人 PHARMACIA CORPORATION;SCRINIVASAN RAJ NAGARAJAN;ISH KUMAR KHANNA;MICHAEL B. TOLLEFSON;SCOTT B. MOHLER;BARBARA CHEN;MARK RUSSELL;BALEKUDRU DEVADAS;THOMAS D PENNING;LORI A. SCHRETZMAN;DALE P. SPANGLER;MARK LAURENCE BOYS;NIZAL SAMUEL CHANDRAKUMAR;HWANG-FUN LU 发明人 SCRINIVASAN RAJ NAGARAJAN;ISH KUMAR KHANNA;MICHAEL B. TOLLEFSON;SCOTT B. MOHLER;BARBARA CHEN;MARK RUSSELL;BALEKUDRU DEVADAS;THOMAS D PENNING;LORI A. SCHRETZMAN;DALE P. SPANGLER;MARK LAURENCE BOYS;NIZAL SAMUEL CHANDRAKUMAR;HWANG-FUN LU
分类号 A61K31/4245;A61K31/4375;A61K31/4439;A61K31/444;A61K31/4545;A61K31/4709;A61K31/496;A61K31/5383;A61P3/14;A61P9/00;A61P9/08;A61P9/10;A61P19/02;A61P19/10;A61P21/00;A61P27/02;A61P35/00;A61P43/00;C07D213/74;C07D231/38;C07D233/60;C07D233/88;C07D405/12;C07D413/06;C07D413/12;C07D413/14;C07D417/12;C07D471/04;C07D498/04 主分类号 A61K31/4245
代理机构 代理人
主权项
地址